CClinicalTrials.gg
CompletedNCT01604096LOCAALUpdated May 23, 2012

Controlled Trial to Evaluate a Local Information Campaign on Antibiotic Prescribing in Italy

A Phase 2 interventional study of Multifaceted information campaign in Upper Respiratory Tract Infections, sponsored by Regional Health and Social Care Agency, Italy. Completed at 2 sites in Italy. Per ClinicalTrials.gov, last updated 2012-05-23.

Sponsored by Regional Health and Social Care Agency, Italy · Phase 2 and Interventional

Phase
Phase 2
Study type
Interventional
Allocation
Non-randomized
Sex
All
01

Study summary

Use of information campaigns and educational interventions directed to citizens and supported by physicians, aimed at promoting the appropriate use of medicines, have been evaluated by several studies with conflicting results. These interventions are potentially relevant, favouring the reduction of unnecessary use of medicines and related risks. Several studies have specifically evaluated the promotion of the appropriate use of antibiotics in adults and children, with variable results. A controlled study has been proposed to evaluate the feasibility and effectiveness of a multifaceted intervention aimed at reducing antibiotic prescription by increasing awareness on risks of their unnecessary use.

Information has been provided to citizens through several media (posters, local TV, radio and newspapers, video terminals, websites of Local Health Authorities). Brochures with information on expected benefits and risks of antibiotics has also been available, either with direct access in waiting rooms and pharmacies or handed out and mediated by doctors. Physicians and pharmacists received specific data on local antibiotic resistance. A small group of representative doctors have also actively participated in defining the campaign key messages. A sample of general practitioners and paediatricians have been trained in patient counselling strategies.

The information campaign has been implemented in two Provinces of Emilia-Romagna during the fall-winter season (November 2011-February 2012). Change in the overall prescribing rate of antibiotics (expressed as DDD per 1000 inhabitants/day) in the intervention area will be compared versus other areas in the same Region. Knowledge and attitudes of the general population will be evaluated through a phone and internet survey on a representative sample.

This study could observe a reduction lower than 5% in the prescribing rate of antibiotics.

02

Conditions studied

  • Upper Respiratory Tract Infections

Keywords

  • Information
  • campaign
  • antibiotics
  • bacterial resistance
  • primary care
03

In context

Respiratory Tract Infections

1,031 studies on the registry are indexed under Respiratory Tract Infections; 144 are open to participants now.

Browse Respiratory Tract Infections studies →

Lead sponsor

This is the only study on the registry with Regional Health and Social Care Agency, Italy as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All

Eligibility criteria

Inclusion Criteria:

  • the campaign has been targeted at the general population in the intervention areas
05

Study design

Phase
Phase 2
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)

Study arms

  • Experimental
    Intervention areas

    Provinces of Modena and Parma (about 1.100.000 inhabitants - campaign targeted to the general population), in Northern Italy (Emilia-Romagna Region)

    Other: Multifaceted information campaign

  • No intervention
    Control

    All the other provinces in the Emilia-Romagna Region (where the information campaign has not been implemented)

Interventions

  • OtherMultifaceted information campaign

    Following is the description of the multifaceted intervention: * brochures targeted at the general population and available in general practices, pharmacies, local health services and on the web (also translated in eight languages) * posters (same distribution as brochures) * short videos transmitted in local TVs, websites of Local Health Authorities and in video terminals in some pharmacies * radio-spots transmitted in local radio stations * advertisements in local newspapers * banners on websites of local newspapers * newsletter on antibiotic resistance in Emilia- Romagna, available to physicians and pharmacists * training courses in counselling strategies, directed to a subgroup of GPs and paediatricians

06

What researchers measure

Primary outcomes

  1. Prescribing rate of antibiotics

    Cumulative five-month changes in DDD per 1000 inhabitants/day of specific classes of antibiotics (J01C, J01D, J01F, J01M ATC codes) in general practice

    Time frame: up to 03/12

Secondary outcomes

  1. Antibiotic prescribing trends

    Changes in antibiotic prescribing trends in eighteen months (same ATCs as for primary outcome)

    Time frame: up to 04/13

  2. Antibiotic expenditure

    Changes in antibiotic expenditure per 1000 inhabitants/day (same ATCs as for primary outcome)

    Time frame: up to 03/12

  3. Knowledge/attitudes of the general population

    Knowledge of and attitudes about the campaign messages, through a telephone and internet survey on a sample of the target population.

    Time frame: up to 02/12

07

Study locations

2 sites
  • Local Health Authority of Modena
    Modena, 41100, Italy
  • Local Health Authority of Parma
    Parma, 43100, Italy
08

References and documents

Publications

  • LOcal Campaign on Antibiotics ALliance (LOCAAL) study group. Doctors and local media: a synergy for public health information?: a controlled trial to evaluate the effects of a multifaceted campaign on antibiotic prescribing (protocol). BMC Public Health. 2011 Oct 19;11:816. doi: 10.1186/1471-2458-11-816. PubMed 22011332 ↗
  • Formoso G, Paltrinieri B, Marata AM, Gagliotti C, Pan A, Moro ML, Capelli O, Magrini N; LOCAAL Study Group. Feasibility and effectiveness of a low cost campaign on antibiotic prescribing in Italy: community level, controlled, non-randomised trial. BMJ. 2013 Sep 12;347:f5391. doi: 10.1136/bmj.f5391. PubMed 24030722 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 23, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01604096
Lead sponsor
Regional Health and Social Care Agency, Italy
Collaborators
Local Health Authority, Parma, Local Health Authority, Modena, Change Institute, Turin
Responsible party
Sponsor
First posted
May 23, 2012
Start date
Nov 2011
Primary completion
Mar 2012
Completion
Mar 2012
Last update
May 23, 2012

Study contacts

Giulio Formoso, MPH, MPharm
principal investigator · Regional Health and Social Care Agency, Emilia Romagna Region (Italy)

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion